Estrella Immunopharma Inc... (ESLA)
NASDAQ: ESLA
· Real-Time Price · USD
0.91
0.05 (5.76%)
At close: Aug 15, 2025, 3:59 PM
0.89
-1.70%
After-hours: Aug 15, 2025, 04:12 PM EDT
Estrella Immunopharma Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -12.08M | -10.48M | -8.85M | -8.82M | -7.31M | -3.53M | -3.21M | -4.95M | -3.62M | -4.53M | -4.55M | -1.9M | -1.46M | -382.3K | -214K | -108.11K | n/a |
Interest Income | n/a | n/a | n/a | n/a | n/a | 114.31K | 220.1K | 601.99K | 806.3K | 691.99K | 586.2K | 204.31K | 567.00 | 571.00 | 571.00 | 571.00 | 4.00 |
Pretax Income | -12.08M | -10.48M | -8.85M | -8.82M | -7.31M | -3.42M | -2.99M | -4.73M | -3.2M | -4.22M | -4.34M | -1.69M | -1.46M | -385.29K | -217K | -111.1K | -3.56K |
Net Income | -12.08M | -10.48M | -8.85M | -8.82M | -7.31M | -3.44M | -3.03M | -4.77M | -3.24M | -4.24M | -4.34M | -1.69M | -1.46M | -385.29K | -217K | -111.1K | -3.56K |
Selling & General & Admin | 3.15M | 2.69M | 2.44M | 2.36M | 3.2M | 2.93M | 2.62M | 1.83M | 963.77K | 840.74K | 685.94K | 569.93K | 56.92K | 24.67K | 42.91K | 10.51K | n/a |
Research & Development | 8.93M | 7.79M | 6.41M | 6.45M | 4.11M | 583.92K | 3.18M | 5.71M | 5.23M | 6.27M | 3.84M | 1.3M | 1.3M | 260.03K | 73.49K | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -13.94K | -27.04K | -27.04K | -52.7K | -38.76K | -25.66K | -25.66K | -97.6K | -97.6K | -97.6K | -97.6K | n/a |
Operating Expenses | 12.08M | 10.48M | 8.85M | 8.82M | 7.31M | 3.53M | 3.21M | 4.95M | 3.62M | 4.53M | 4.55M | 1.9M | 1.46M | 382.3K | 214.01K | 108.11K | n/a |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 18.84K | 18.84K | 18.84K | 18.84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.08M | 10.48M | 8.85M | 8.82M | 7.31M | 3.53M | 3.21M | 4.95M | 3.62M | 4.53M | 4.55M | 1.9M | 1.46M | 382.3K | 214.01K | 108.11K | n/a |
Income Tax Expense | 926.00 | 1.7K | 1.69K | 1.63K | 1.63K | 21.08K | 40.54K | 40.54K | -19.92K | -48.21K | -67.68K | -122.63K | -62.17K | -54.95K | -54.95K | n/a | n/a |
Shares Outstanding (Basic) | 36.17M | 36.19M | 36.68M | 36.21M | 36.61M | 35.52M | 35.2M | 1.05M | 2.33M | 2.33M | 2.33M | 5.85M | 35.2M | 5.85M | 35.2M | 5.85M | 6.07M |
Shares Outstanding (Diluted) | 36.17M | 36.19M | 36.68M | 36.21M | 36.61M | 35.52M | 35.2M | 1.05M | 2.33M | 2.33M | 2.33M | 5.85M | 35.2M | 5.85M | 35.2M | 5.85M | 6.07M |
EPS (Basic) | -0.33 | -0.29 | -0.25 | -0.25 | -1.93 | -1.85 | -1.87 | -3.02 | -1.3 | -1.3 | -1.3 | -0.12 | -0.08 | -0.05 | -0.02 | -0.02 | -0.00 |
EPS (Diluted) | -0.33 | -0.29 | -0.25 | -0.25 | -1.93 | -1.85 | -1.87 | -3.02 | -1.3 | -1.3 | -1.3 | -0.12 | -0.08 | -0.05 | -0.02 | -0.02 | -0.00 |
EBITDA | -12.08M | -10.48M | -8.85M | -8.82M | -7.31M | -6.09M | -8.36M | -10.09M | -8.77M | -7.12M | -4.55M | -1.9M | -1.46M | -385.29K | -217K | -111.1K | -3.56K |
EBIT | -12.08M | -10.48M | -8.85M | -8.82M | -7.31M | -6.09M | -8.36M | -10.1M | -11.11M | -9.46M | -6.88M | -4.23M | -1.46M | -385.29K | -217K | -111.1K | -3.56K |
Depreciation & Amortization | n/a | n/a | -39.59K | 82.5K | 124.08K | 178.96K | 224.04K | 101.95K | 120.83K | 137.34K | 185.85K | 241.66K | 181.2K | 109.81K | 55.81K | n/a | n/a |